Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization

Pediatric Pulmonology

Volumn 32, Issue 4, 2001, Pages 288-292

  Munck, Anne ^a   Bonacorsi, Stéphane ^a   Mariani Kurkdjian, Patricia ^a   Lebourgeois, Muriel ^a   Gérardin, Michèle ^a   Brahimi, Nama ^a   Navarro, Jean ^a   Bingen, Edouard ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Bacterial genotyping; Cystic fibrosis; Molecular analysis; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CEFTAZIDIME; COLISTIN; IMIPENEM; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ERADICATION THERAPY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFANT; LUNG INFECTION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SPUTUM CULTURE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COLISTIN; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; IMIPENEM; INFANT; MALE; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK ASSESSMENT; TOBRAMYCIN;

EID: 0034785372     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.1121     Document Type: Article

References (24)

1. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia
2. Further insights into early acquisition of Pseudomonas aeruginosa
3. Prevention of chronic Pseudomonas aeruginosa colonization in cystic fibrosis by early treatment
4. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis
5. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
6. Nebulised colimycin for early Pseudomonas aeruginosa colonisation in cystic fibrosis
7. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995)
8. Treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis
9. Microbiology of airway disease in patients with cystic fibrosis
10. Microbiology of sputum from patients at cystic fibrosis centers in the United States
11. Molecular analysis of multiply recurrent meningitis due to Escherichia coli K1 in an infant
12. Molecular epidemiology provides evidence of genotypic heterogeneity of multidrug-resistant Pseudomonas aeruginosa serotype O:12 outbreak isolates from a pediatric hospital
13. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients
14. Discriminatory power of three DNA-Based typing techniques for Pseudomonas aeruginosa
15. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey
16. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: More questions than answers
17. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis
18. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis
19. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa
20. A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis
21. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa
22. Management of pulmonary disease in patients with cystic fibrosis
23. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibosis
24. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen